Long-term safety and efficacy of mexiletine for patients with skeletal muscle channelopathies

KJ Suetterlin, E Bugiardini, JP Kaski, JM Morrow… - JAMA …, 2015 - jamanetwork.com
Methods| All patients with genetically confirmed nondystrophic myotonia or hyperkalemic
periodic paralysis prescribed mexiletine with a minimum of 6 months follow-up in our clinic
were included. Study data were collected as part of a clinical audit registered with the
hospital audit committee. This study received ethical approval from the National Hospital for
Neurology and Neurosurgery and Institute of Neurology Joint Research Ethics committee.
Because data were collected as part of a clinical audit, such evaluations do not require …
以上显示的是最相近的搜索结果。 查看全部搜索结果